These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 35893683)

  • 1. Recombinant Bovine Herpesvirus Type I Expressing the Bovine Viral Diarrhea Virus E2 Protein Could Effectively Prevent Infection by Two Viruses.
    Liu CY; Guo H; Zhao HZ; Hou LN; Wen YJ; Wang FX
    Viruses; 2022 Jul; 14(8):. PubMed ID: 35893683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle.
    Williams LBA; Fry LM; Herndon DR; Franceschi V; Schneider DA; Donofrio G; Knowles DP
    PLoS One; 2019; 14(4):e0215605. PubMed ID: 31002724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of reproductive protection against bovine viral diarrhea virus and bovine herpesvirus-1 afforded by annual revaccination with modified-live viral or combination modified-live/killed viral vaccines after primary vaccination with modified-live viral vaccine.
    Walz PH; Givens MD; Rodning SP; Riddell KP; Brodersen BW; Scruggs D; Short T; Grotelueschen D
    Vaccine; 2017 Feb; 35(7):1046-1054. PubMed ID: 28111144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an APC-targeted multivalent E2-based vaccine against Bovine Viral Diarrhea Virus types 1 and 2.
    Pecora A; Malacari DA; Perez Aguirreburualde MS; Bellido D; Nuñez MC; Dus Santos MJ; Escribano JM; Wigdorovitz A
    Vaccine; 2015 Sep; 33(39):5163-71. PubMed ID: 26279338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic Cell Targeting of Bovine Viral Diarrhea Virus E2 Protein Expressed by
    Wang Y; Feng B; Niu C; Jia S; Sun C; Wang Z; Jiang Y; Cui W; Wang L; Xu Y
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31242608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A triple gene mutant of BoHV-1 administered intranasally is significantly more efficacious than a BoHV-1 glycoprotein E-deleted virus against a virulent BoHV-1 challenge.
    Chowdhury SI; Wei H; Weiss M; Pannhorst K; Paulsen DB
    Vaccine; 2014 Sep; 32(39):4909-15. PubMed ID: 25066735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiepitope fusion antigen elicits neutralizing antibodies against enterotoxigenic Escherichia coli and homologous bovine viral diarrhea virus in vitro.
    Hashish EA; Zhang C; Ruan X; Knudsen DE; Chase CC; Isaacson RE; Zhou G; Zhang W
    Clin Vaccine Immunol; 2013 Jul; 20(7):1076-83. PubMed ID: 23697572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
    Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
    Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection induced by a glycoprotein E-deleted bovine herpesvirus type 1 marker strain used either as an inactivated or live attenuated vaccine in cattle.
    Romera SA; Puntel M; Quattrocchi V; Del Médico Zajac P; Zamorano P; Blanco Viera J; Carrillo C; Chowdhury S; Borca MV; Sadir AM
    BMC Vet Res; 2014 Jan; 10():8. PubMed ID: 24401205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vaccination of pregnant beef heifers on the concentrations of serum IgG and specific antibodies to bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 in heifers and calves.
    Reppert EJ; Chamorro MF; Robinson L; Cernicchiaro N; Wick J; Weaber RL; Haines DM
    Can J Vet Res; 2019 Oct; 83(4):313-316. PubMed ID: 31571732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant.
    Jia S; Huang X; Li H; Zheng D; Wang L; Qiao X; Jiang Y; Cui W; Tang L; Li Y; Xu Y
    Microb Cell Fact; 2020 Oct; 19(1):186. PubMed ID: 33004035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BoHV-1-Vectored BVDV-2 Subunit Vaccine Induces BVDV Cross-Reactive Cellular Immune Responses and Protects against BVDV-2 Challenge.
    Chowdhury SI; Pannhorst K; Sangewar N; Pavulraj S; Wen X; Stout RW; Mwangi W; Paulsen DB
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33451136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
    Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
    Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus detection by PCR following vaccination of naive calves with intranasal or injectable multivalent modified-live viral vaccines.
    Walz PH; Newcomer BW; Riddell KP; Scruggs DW; Cortese VS
    J Vet Diagn Invest; 2017 Sep; 29(5):628-635. PubMed ID: 28545321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of reproductive performance of primiparous dairy cattle following revaccination with either modified-live or killed multivalent viral vaccines in early lactation.
    Walz PH; Montgomery T; Passler T; Riddell KP; Braden TD; Zhang Y; Galik PK; Zuidhof S
    J Dairy Sci; 2015 Dec; 98(12):8753-63. PubMed ID: 26454300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an inactivated, recombinant bovine herpesvirus type 5 (BoHV-5) vaccine.
    Campos FS; Dezen D; Antunes DA; Santos HF; Arantes TS; Cenci A; Gomes F; Lima FE; Brito WM; Filho HC; Batista HB; Spilki FR; Franco AC; Rijsewijk FA; Roehe PM
    Vet Microbiol; 2011 Feb; 148(1):18-26. PubMed ID: 20828945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Quadruple Gene-Deleted Live BoHV-1 Subunit RVFV Vaccine Vector Reactivates from Latency and Replicates in the TG Neurons of Calves but Is Not Transported to and Shed from Nasal Mucosa.
    Pavulraj S; Stout RW; Paulsen DB; Chowdhury SI
    Viruses; 2024 Sep; 16(9):. PubMed ID: 39339973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA prime protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge.
    Liang R; van den Hurk JV; Landi A; Lawman Z; Deregt D; Townsend H; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2008 Feb; 89(Pt 2):453-466. PubMed ID: 18198376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mosaic Bovine Viral Diarrhea Virus Antigens Elicit Cross-Protective Immunity in Calves.
    Sangewar N; Hassan W; Lokhandwala S; Bray J; Reith R; Markland M; Sang H; Yao J; Fritz B; Waghela SD; Abdelsalam KW; Chase CCL; Mwangi W
    Front Immunol; 2020; 11():589537. PubMed ID: 33281819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.